Cardiac stress agents

0 marketed 1 in Phase 3

This page covers all Cardiac stress agents drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine A2A receptor (adenosine); dopamine and beta-adrenergic receptors (dobutamine); adenosine A2A receptor (regadenoson).

Targets

Adenosine A2A receptor (adenosine); dopamine and beta-adrenergic receptors (dobutamine); adenosine A2A receptor (regadenoson)

Phase 3 pipeline (1)

Patent intelligence